It was recognizable that the highest prognostic impact with a hazard ratio of 3.89 and a significantly prolonged survival was seen for the subgroup of GBM patients with a high expression of S1P1 combined with a low expression of S1P2 (Supplementary Figure S2H). The gene discussed is S1PR1; the disease is glioblastoma.